India has its eyes on its first coronavirus vaccine, and it may get one very soon. Covishield, the Oxford University-Astra Zeneca vaccine candidate, will be commercialized in 73 days, a Business Today report said. Indians will be immunized free under the National Immunization Programme (NIP), it further mentioned. Phase III trials of the vaccine are being handled by the Serum Institute of India. Quoting sources, the report said that the company has entered into an “exclusive agreement with Astra Zeneca to buy rights and pay a royalty fee for exclusively selling it in India and 92 other countries.